This company has been acquired
LHCG Stock Overview
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
LHC Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$169.81 |
| 52 Week High | US$169.84 |
| 52 Week Low | US$115.32 |
| Beta | 0.42 |
| 1 Month Change | 3.76% |
| 3 Month Change | 0.91% |
| 1 Year Change | 32.12% |
| 3 Year Change | 30.61% |
| 5 Year Change | 178.06% |
| Change since IPO | 893.04% |
Recent News & Updates
Recent updates
LHC Group GAAP EPS of $0.35 misses by $0.95, revenue of $576.2M misses by $29.82M
Aug 03LHC Group: UnitedHealth Merger Is Worth Playing
Jul 19FTC second request in LHC Group/UnitedHealth said to probe pay, labor market
Jul 06These 4 Measures Indicate That LHC Group (NASDAQ:LHCG) Is Using Debt Safely
Feb 24
With EPS Growth And More, LHC Group (NASDAQ:LHCG) Is Interesting
Feb 06LHC Group (NASDAQ:LHCG) Has A Rock Solid Balance Sheet
Nov 25Is Now The Time To Put LHC Group (NASDAQ:LHCG) On Your Watchlist?
Nov 07Why We Think Shareholders May Be Considering Bumping Up LHC Group, Inc.'s (NASDAQ:LHCG) CEO Compensation
Jun 03LHC Group, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 10With EPS Growth And More, LHC Group (NASDAQ:LHCG) Is Interesting
Mar 25Are LHC Group, Inc.'s (NASDAQ:LHCG) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 07Is LHC Group, Inc. (NASDAQ:LHCG) Trading At A 45% Discount?
Feb 17Does LHC Group (NASDAQ:LHCG) Have A Healthy Balance Sheet?
Feb 04
LHC Group, Inc. (NASDAQ:LHCG) Insiders Have Been Selling
Jan 19Here's Why LHC Group's (NASDAQ:LHCG) Statutory Earnings Are Arguably Too Conservative
Jan 06Here's Why We Think LHC Group (NASDAQ:LHCG) Is Well Worth Watching
Dec 24Did You Miss LHC Group's (NASDAQ:LHCG) Whopping 338% Share Price Gain?
Dec 12LHC Group, Inc. (NASDAQ:LHCG) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 30Estimating The Fair Value Of LHC Group, Inc. (NASDAQ:LHCG)
Nov 18LHC Group, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 09Shareholder Returns
| LHCG | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0.6% | 2.4% | -3.7% |
| 1Y | 32.1% | 0.8% | 20.5% |
Return vs Industry: LHCG exceeded the US Healthcare industry which returned -0.3% over the past year.
Return vs Market: LHCG exceeded the US Market which returned -9% over the past year.
Price Volatility
| LHCG volatility | |
|---|---|
| LHCG Average Weekly Movement | 2.1% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LHCG has not had significant price volatility in the past 3 months.
Volatility Over Time: LHCG's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 23,000 | Keith Myers | www.lhcgroup.com |
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy.
LHC Group, Inc. Fundamentals Summary
| LHCG fundamental statistics | |
|---|---|
| Market cap | US$5.29b |
| Earnings (TTM) | US$39.87m |
| Revenue (TTM) | US$2.28b |
132.7x
P/E Ratio2.3x
P/S RatioIs LHCG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LHCG income statement (TTM) | |
|---|---|
| Revenue | US$2.28b |
| Cost of Revenue | US$1.40b |
| Gross Profit | US$883.61m |
| Other Expenses | US$843.74m |
| Earnings | US$39.87m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.28 |
| Gross Margin | 38.71% |
| Net Profit Margin | 1.75% |
| Debt/Equity Ratio | 43.0% |
How did LHCG perform over the long term?
See historical performance and comparison